对于非小细胞肺癌和食道癌的新辅助疗法
Yunlong He1,2, Yaqi Zhao1, Muhammad Luqman Akhtar1
1School of Life Science and Technology, Harbin Institute of Technology Harbin 150008, Heilongjiang, China.
American journal of cancer research
|April 9, 2024
概括
对非小细胞肺癌 (NSCLC) 和食道癌 (EC) 的新新辅助疗法至关重要. 本综述探讨了个性化新辅助治疗的新策略,旨在改善患者的治疗结果并减少癌症复发.
科学领域:
- 在瘤学瘤学.
- 胸部外科手术 胸部外科手术
- 癌症治疗方法 癌症治疗方法
背景情况:
- 非小细胞肺癌 (NSCLC) 和食道癌 (EC) 是全球癌症相关死亡的主要原因.
- 手术是主要的治疗方法,但高复发率和转移导致预后不佳.
- 在手术前进行的新辅助疗法显示出潜力,但由于患者反应的变化而面临挑战.
研究的目的:
- 对胸部恶性瘤的新兴新辅助疗法方案和策略进行审查和总结.
- 突出需要个性化的新辅助方法来优化治疗疗效.
- 讨论可能改善NSCLC和EC患者生活质量的新疗法选择.
主要方法:
- 关于新辅助治疗NSCLC和EC的最新进展的文献综述.
- 分析新型治疗策略及其潜在的临床应用.
- 在新辅助瘤学中对个性化医学进行当前研究的综合.
主要成果:
- 新辅助疗法提供了潜在的好处,但需要针对个体患者量身定制的方法.
- 新兴的策略旨在增强治疗反应并尽量减少副作用.
- 个性化的新辅助疗法对于改善生存和生活质量至关重要.
结论:
- 开发个性化的新辅助疗法对于改善NSCLC和EC的结果至关重要.
- 新型治疗策略有望提高治疗疗效和患者福祉.
- 对个性化新辅助治疗的进一步研究是有必要的,以克服目前的局限性.
相关概念视频
Barrett Esophagus-II: Clinical Manifestations and Management
141
Individuals with Barrett's esophagus are often asymptomatic, but they may experience symptoms commonly associated with GERD, such as heartburn and acid regurgitation. Additional symptoms can include difficulty swallowing, chest pain, unintentional weight loss, blood in the stool (which may appear black, tarry, or bloody), and episodes of vomiting.
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure...
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure...
141
Gastroesophageal Reflux Disease II: Clinical Features and Management
76
Gastroesophageal reflux disease, or GERD, is a persistent medical condition that affects many individuals worldwide. Its clinical manifestations can vary greatly, making diagnosis and management challenging for healthcare professionals. The following is a comprehensive overview of the clinical manifestations, assessment, and management strategies for GERD.
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
76
Esophageal Strictures-II: Clinical Features and Management
68
Patients with esophageal strictures often experience a range of symptoms. Initially, they may have difficulty swallowing solid foods, which can progress to include liquids. Additional symptoms may involve chest pain or discomfort, regurgitating food and fluids, heartburn, unintentional weight loss, coughing or choking during meals, and hoarseness.
Healthcare providers should gather a comprehensive medical history and conduct a physical examination for diagnosis. If esophageal stricture is...
Healthcare providers should gather a comprehensive medical history and conduct a physical examination for diagnosis. If esophageal stricture is...
68
Barrett Esophagus-I: Introduction
87
Barrett's esophagus is a medical condition where the esophageal mucosa is significantly damaged by stomach acid or other digestive fluids, often due to long-term exposure associated with gastroesophageal reflux disease (GERD). In GERD, a weakened or abnormally relaxed lower esophageal sphincter allows stomach acid to flow persistently into the esophagus.
This constant acid exposure transforms the esophagus's pink mucosal lining (stratified squamous epithelium) into a type of lining more...
This constant acid exposure transforms the esophagus's pink mucosal lining (stratified squamous epithelium) into a type of lining more...
87
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
198
5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
198
Endoscopic Procedures I: Esophagogastroduodenoscopy
111
An Esophagogastroduodenoscopy (EGD) is a diagnostic procedure in which an endoscopist uses a flexible, lighted endoscope to visualize the upper gastrointestinal (GI) tract. The procedure includes visualizing the oropharynx, esophagus, stomach, and the first part of the small intestine, the duodenum.
During an EGD, the endoscope can be used to:
During an EGD, the endoscope can be used to:
111


